Home › Research › Down syndrome and Alzheimer's
Growth properties and in vitro life span of Alzheimer disease and Down syndrome fibroblasts. A blind study
Carmeliet G, Hauman R, Dom R, David G, Fryns JP, Van den Berghe H, Cassiman JJ.. Mechanisms of ageing and development, 1990-03-01
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
A blind study was set up to examine the in vitro growth characteristics of skin fibroblasts from 2 individuals with and 9 at risk for familial Alzheimer disease, 4 individuals with sporadic Alzheimer disease, 18 with Down syndrome as well as 5 younger and 6 older controls. Several variables (biopsy size, number of explants, medium, passage procedure) were standardized. Two growth characteristics were examined quantitatively: (i) the actual in vitro replicating life span was determined by counting the number of cells plated the previous week at 500,000 cells/flask (cumulative population doublings); and (ii) the growth potential was examined by a colony size distribution assay. A difference from the age-matched controls in the growth characteristics of skin fibroblasts was only observed for two patients with and one older individual at risk for familial Alzheimer disease. The growth properties of skin fibroblast cultures from patients with sporadic Alzheimer disease or Down syndrome were not at variance with their age-matched controls. The decrease in the growth potential observed in the familial Alzheimer disease fibroblasts is however modest and needs confirmation. It is clear that the growth properties of skin fibroblasts, as examined in this study, do not provide a good marker for any form of Alzheimer disease, nor do they provide an appropriate in vitro system to study factors which may contribute to the etiopathogenesis of Alzheimer disease or Down syndrome.
What this study adds
Evidence grade: Low
Skin fibroblast growth properties did not differ from age-matched controls in people with sporadic Alzheimer disease or Down syndrome, and only a modest difference was seen in a few familial Alzheimer disease cases that the authors say needs confirmation. The authors conclude these growth properties are not a good marker for any form of Alzheimer disease.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Carmeliet, G., Hauman, R., Dom, R., David, G., Fryns, J. P., Van den Berghe, H., et al. (1990). Growth properties and in vitro life span of Alzheimer disease and Down syndrome fibroblasts. A blind study. Mechanisms of ageing and development. https://doi.org/10.1016/0047-6374(90)90031-a
Vancouver
Carmeliet G, Hauman R, Dom R, David G, Fryns JP, Van den Berghe H, et al. Growth properties and in vitro life span of Alzheimer disease and Down syndrome fibroblasts. A blind study. Mechanisms of ageing and development. 1990. doi:10.1016/0047-6374(90)90031-a. PMID: 2139155.
BibTeX
@article{carmeliet1990-2139155,
author = {Carmeliet, G. and Hauman, R. and Dom, R. and David, G. and Fryns, J. P. and Van den Berghe, H. and Cassiman, J. J.},
title = {{Growth properties and in vitro life span of Alzheimer disease and Down syndrome fibroblasts. A blind study}},
journal = {Mechanisms of ageing and development},
year = {1990},
doi = {10.1016/0047-6374(90)90031-a},
pmid = {2139155},
url = {https://doi.org/10.1016/0047-6374(90)90031-a}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record names 7 authors; APA and Vancouver show the first six, BibTeX and the downloads carry all of them. Check the citation against the original before you use it.
Key findings
- Two growth characteristics were examined quantitatively: (i) the actual in vitro replicating life span was determined by counting the number of cells plated the previous week at 500,000 cells/flask (cumulative population doublings); and (ii) the growth potential was examined by a colony size distribution assay.
- A difference from the age-matched controls in the growth characteristics of skin fibroblasts was only observed for two patients with and one older individual at risk for familial Alzheimer disease.
- The growth properties of skin fibroblast cultures from patients with sporadic Alzheimer disease or Down syndrome were not at variance with their age-matched controls.
- The decrease in the growth potential observed in the familial Alzheimer disease fibroblasts is however modest and needs confirmation.
- It is clear that the growth properties of skin fibroblasts, as examined in this study, do not provide a good marker for any form of Alzheimer disease, nor do they provide an appropriate in vitro system to study factors which may contribute to the etiopathogenesis of Alzheimer disease or Down syndrome.
Why it matters
Skin fibroblast growth properties did not differ from age-matched controls in people with sporadic Alzheimer disease or Down syndrome, and only a modest difference was seen in a few familial Alzheimer disease cases that the authors say needs confirmation. The authors conclude these growth properties are not a good marker for any form of Alzheimer disease.
Study details
- Evidence strengthLow
How this study scored 30/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Mechanisms of ageing and development) |
| Journal's citation record | 2 / 4 | Mechanisms of Ageing and Development: journal h-index 172 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 1 / 5 | 1990 — older than 20 years, still counted |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Laboratory or animal study (title names “in vitro”) — scores zero |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 2 / 7 | Cited 11 times (OpenAlex, 2026-10-10) |
| Citations per year | 0 / 5 | 0.3 citations a year over 38 year(s) since 1990 |
| Impact for its field and year | 2 / 6 | Cited 1.3× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 0 / 4 | Cited 0 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 2 / 4 | Last-listed author Jean‐Jacques Cassiman: h-index 45 (OpenAlex, whole career) |
| Institution's track record | 1 / 3 | KU Leuven: institution h-index 1,386 (OpenAlex) |
| Multicenter collaboration | 0 / 3 | OpenAlex lists 1 institution(s) in 1 country — scores zero (affiliation lists can be incomplete) |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 2139155) |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Total | 30 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
May need a subscription OpenAlex found no free copy of the full text (checked 6 Feb 1020), so the publisher may charge for it. The PubMed abstract is free.
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Related studies in Down syndrome and Alzheimer's from nearby years
Also tagged “down”
527 studies in the library carry the topic tag “down”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 527 tagged studies.